Clinical Trials Directory

Trials / Completed

CompletedNCT05024669

Efficacy of Desensitizers in Reducing Post-operative Sensitivity Following Composite Restorations

Efficacy of Three Commercially Available Desensitizers in Reducing Post-operative Sensitivity Following Composite Restorations: A Randomized Controlled Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Jazan · Other Government
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Composite is one of the common aesthetic restorations used in the dentistry. With the advancements in the biomaterials the application of the composites has broadened. However due to various factors the composites are associated with dental sensitivity. Hence in our study we evaluate and compare the effectiveness of three desensitizing agents in reducing the post-treatment sensitivity for class I composite restoration.

Detailed description

A double-blind, randomized, controlled clinical trial was conducted in which 80 subjects requiring class I cavity were randomly assigned to 4 groups of 20 patients each: Group C (Control group), Group GL (Gluma group), Group SF (Shield Force Plus group), and Group TC (Telio CS group). The class 1 cavity was prepared and after etching, the desensitizers were applied (except in the control group) and later composite restoration was done. The postoperative pain/sensitivity level was recorded according to the Visual Analogue Scale (VAS) on intake of cold drinks; intake of hot drinks; and intake of sugar for different periods of time.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTGluma desensitiserGluma desensitiser was used before restoration.
COMBINATION_PRODUCTSheildforce Plus desensitiserSheildforce Plus desensitiser was used before restoration.
COMBINATION_PRODUCTTelio CS desensitiserTelio CS desensitiser was used before restoration.

Timeline

Start date
2020-12-10
Primary completion
2021-04-10
Completion
2021-05-10
First posted
2021-08-27
Last updated
2021-08-27

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT05024669. Inclusion in this directory is not an endorsement.